The Truth Behind Trump’s “Retaliation” Threat

Indicating a diplomatic failure of Narendra Modi government, a barrage of misinformation was peddled by the Lutyens media over Donald Trump’s retaliation threat, if India did not export Chinese virus related anti-malarial drug hydroxychloroquine to the US.

The question is – Why we call it a misinformation, or specifically, did Trump really threaten India with retaliation over hydroxychloroquine export?

ISD 4:1 के अनुपात से चलता है। हम समय, शोध, संसाधन, और श्रम (S4) से आपके लिए गुणवत्तापूर्ण कंटेंट लाते हैं। आप अखबार, DTH, OTT की तरह Subscription Pay (S1) कर उस कंटेंट का मूल्य चुकाते हैं। इससे दबाव रहित और निष्पक्ष पत्रकारिता आपको मिलती है।

यदि समर्थ हैं तो Subscription अवश्य भरें। धन्यवाद।

The controversial statement of Trump was first flashed on the twitter handle of ANI at 4 am on April 7. “I spoke to him (PM Modi), Sunday morning and I said we appreciate it that you are allowing our supply (of medicines) to come out, if he doesn’t allow it come out, that would be okay, but of course, there may be retaliation, why wouldn’t there be?: US Pres Donald Trump,” ANI tweeted.

This gave ample fodder for left-liberal cabal and Lutyens media to grind, calling it as a diplomatic failure of Narendra Modi’s government, but they did not check the Directorate General of Foreign Trade notification dated April 6, which is required for a professional journalist for cross-checking.

The notification makes it clear that the Chinese virus related formulations and drugs including hydrooxychloroquine, are made free for exports, with immediate effect – that is from April 6, a day before the controversial remarks of Trump.

Moreover, the White House reporter, who asked Trump this question, should also have updated himself about India’s position on the exports of drugs related to the deadly virus.

The reporter had asked Trump – whether he is worried about retaliation to his decision to ban the export of medical goods, like Indian Prime Minister Modi’s decision to not export hydroxychloroquine to the United States and other countries.

Trump’s response, stated above, is more of a response to a query rather than a unilateral response to India.

Perhaps, Trump should have been more careful in giving a response than falling into the trap of the media, which believes more in spinning stories out of a plain statement.

Yesterday, the Ministry of External Affairs (MEA) Spokesman Anurag Srivastava rapped by sections of media for creating needless controversy over the issue of Covid-19 related drugs and pharmaceuticals.

He also said India would licence paracetamol and hydrooxychloroquine in appropriate quantities to all our neighbouring countries who are dependent on its capabilities.

India also would supply these essential drugs to some nations (read US), who have been particularly badly affected by the pandemic, he said.

“We would therefore discourage any speculation in this regard or any attempts to politicise the matter,” said Srivastava.

Join our Telegram Community to ask questions and get latest news updates Contact us to Advertise your business on India Speaks Daily News Portal
आदरणीय पाठकगण,

ज्ञान अनमोल हैं, परंतु उसे आप तक पहुंचाने में लगने वाले समय, शोध, संसाधन और श्रम (S4) का मू्ल्य है। आप मात्र 100₹/माह Subscription Fee देकर इस ज्ञान-यज्ञ में भागीदार बन सकते हैं! धन्यवाद!  

Select Subscription Plan

OR Use Paypal below:

Select Subscription Plan


Make One-time Subscription Payment

Scan and make the payment using QR Code

Bank Details:
HDFC Current A/C- 07082000002469 & IFSC: HDFC0000708  
Branch: GR.FL, DCM Building 16, Barakhamba Road, New Delhi- 110001
Paytm/UPI/Google Pay/ पे / Pay Zap/AmazonPay के लिए - 9312665127
WhatsApp के लिए मोबाइल नं- 8826291284

You may also read...

Share your Comment

ताजा खबर